Copyright
©The Author(s) 2021.
World J Cardiol. Sep 26, 2021; 13(9): 483-492
Published online Sep 26, 2021. doi: 10.4330/wjc.v13.i9.483
Published online Sep 26, 2021. doi: 10.4330/wjc.v13.i9.483
Table 2 Time in the therapeutic range of the study population
| Variables | All patients, n = 420 | TTR < 60%, n = 178 | TTR ≥ 60%, n = 242 |
| TTR | |||
| mean ± SD | 60.6 ± 20.6 | 41.1 ± 14.7 | 75.0 ± 9.6 |
| Median (IQR) | 64 (27) | 44 (22) | 74 (14) |
| Good (≥ 60%) | 242 (57.6) | - | - |
| Poor (< 60%) | 178 (42.4) | - | - |
- Citation: Lee SL, Ong TJ, Mazlan-Kepli W, Mageswaran A, Tan KH, Abd-Malek AM, Cronshaw R. Patients’ time in therapeutic range on warfarin among atrial fibrillation patients in Warfarin Medication Therapy Adherence Clinic. World J Cardiol 2021; 13(9): 483-492
- URL: https://www.wjgnet.com/1949-8462/full/v13/i9/483.htm
- DOI: https://dx.doi.org/10.4330/wjc.v13.i9.483